Thoughts Regarding LDL-P, ApoB, and Remnants – Cholesterol Code
Measuring cardiovascular disease risk and the importance of apoB - Peter Attia
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk | Circulation
Long-term risk of a major cardiovascular event by apoB, apoA-1, and the apoB /apoA-1 ratio—Experience from the Swedish AMORIS cohort: A cohort study | PLOS Medicine
Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low‐Density Lipoprotein Cholesterol or Non‐High‐Density Lipoprotein Cholesterol | Journal of the American Heart Association
The apoB/apoA-I Ratio is a Strong Predictor of Cardiovascular Risk | IntechOpen
Measuring cardiovascular disease risk and the importance of apoB - Peter Attia
Long-term risk of a major cardiovascular event by apoB, apoA-1, and the apoB /apoA-1 ratio—Experience from the Swedish AMORIS cohort: A cohort study | PLOS Medicine
The apoB/apoA-I Ratio is a Strong Predictor of Cardiovascular Risk | IntechOpen
The relation between ApoB/ApoA-1 ratio and the severity of coronary artery disease in patients with acute coronary syndrome | The Egyptian Heart Journal | Full Text
The apoB/apoA-I Ratio is a Strong Predictor of Cardiovascular Risk | IntechOpen
PDF) Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target
The relation between ApoB/ApoA-1 ratio and the severity of coronary artery disease in patients with acute coronary syndrome | The Egyptian Heart Journal | Full Text
HDL and cardiovascular disease - The Lancet
Measuring cardiovascular disease risk and the importance of apoB - Peter Attia
Metabolites | Free Full-Text | Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target
Long-term risk of a major cardiovascular event by apoB, apoA-1, and the apoB /apoA-1 ratio—Experience from the Swedish AMORIS cohort: A cohort study | PLOS Medicine
Measuring cardiovascular disease risk and the importance of apoB - Peter Attia
The apoB/apoA-I Ratio is a Strong Predictor of Cardiovascular Risk | IntechOpen
SciELO - Brasil - Índice apo B/apo A-I e predição de risco cardiovascular Índice apo B/apo A-I e predição de risco cardiovascular
Assessing Atherosclerotic Cardiovascular Disease Risk with Advanced Lipid Testing: State of the Science | ECR Journal
Lipoprotein(a) Concentration and Risks of Cardiovascular Disease and Diabetes - ScienceDirect
Increased apolipoprotein-B:A1 ratio predicts cardiometabolic risk in patients with juvenile onset SLE - eBioMedicine
